---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-028632"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2023-08-14T23:59:59+00:00"
generated_at: "2026-06-11T13:22:01.541645+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sanara MedTech Q2 revenue up 63% to $15.8M; acquires collagen assets to cut royalties

## Summary
- Q2 2023 net revenues $15.8M (+63% YoY); net loss $1.9M vs net income $0.8M in prior year.
- Completed post-quarter acquisition of collagen-related assets including CellerateRX Surgical and HYCOL.
- Annual royalties on collagen products were $1.8M in 2022; acquisition expected to eliminate those payments.
- Products sold in over 950 facilities and contracted in 3,000+ hospitals/ASCs as of June 30.
- Loss before income taxes improved to $1.9M from $3.4M in Q2 2022 due to slower expense growth.

## SEC filing metadata
- accession: 0001493152-23-028632
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2023-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315223028632/0001493152-23-028632-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315223028632/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-028632
- JSON: https://secwatch.observer/filing/0001493152-23-028632.json
- Plain text: https://secwatch.observer/filing/0001493152-23-028632.txt

## Key facts
- Earnings Releases
  Sanara MedTech Inc. reported the three months ended June 30, 2022 results: revenue $9.7 million, net income net income of $0.8 million.
  - Period: the three months ended June 30, 2022
  - Revenue: $9.7 million
  - Net income: net income of $0.8 million
  - Result: reported results
  source text: wound care uses and five trademarks. Sales Analysis The Company generated net revenues of $15.8 million for the three months ended June 30, 2023, compared to net revenues of $9.7 million for the three months ended June 30, 2022, a 63% increase from the prior year period. The higher net revenues for the three months ended June 30, 2023 were primarily due to
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315223028632/0001493152-23-028632-index.htm
- Earnings Releases
  Sanara MedTech Inc. reported the quarter ended June 30, 2023 results: revenue $15.8 million, net income net loss of $1.9 million.
  - Period: the quarter ended June 30, 2023
  - Revenue: $15.8 million
  - Net income: net loss of $1.9 million
  - Result: reported results
  source text: The Company generated net revenues of $15.8 million for the three months ended June 30, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315223028632/0001493152-23-028632-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.